When Clarity Is Crucial: Regulating Ocular Surface Immunity.

Szczegóły
Abstrakt

Tytuł:: When Clarity Is Crucial: Regulating Ocular Surface Immunity.
Autorzy:: Foulsham W; Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA; University College London (UCL) Institute of Ophthalmology, University College London, London, UK.
Coco G; Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Amouzegar A; Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Chauhan SK; Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. Electronic address: sunil_.
Dana R; Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. Electronic address: reza_.
Źródło:: Trends in immunology [Trends Immunol] 2018 Apr; Vol. 39 (4), pp. 288-301. Date of Electronic Publication: 2017 Dec 14.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Review
Język:: English
Imprint Name(s):: Original Publication: Oxford, UK : Elsevier Science Ltd., c2001-
MeSH Terms:: Immune Privilege*
Immunity, Mucosal*
Eye/*immunology
Inflammation/*immunology
Mucous Membrane/*immunology
Animals ; Homeostasis ; Humans ; Immune Tolerance
References:: Invest Ophthalmol Vis Sci. 2011 Jun 28;52(7):4598-604. (PMID: 21482644)
Immunol Rev. 2014 Jul;260(1):118-28. (PMID: 24942686)
J Immunol. 2004 Sep 1;173(5):3337-47. (PMID: 15322197)
Trends Mol Med. 2009 May;15(5):199-207. (PMID: 19362058)
Transplantation. 2017 Apr;101(4):778-785. (PMID: 27490416)
Am J Ophthalmol. 2017 Oct;182:90-98. (PMID: 28705660)
Int J Mol Sci. 2017 May 05;18(5):. (PMID: 28475124)
Invest Ophthalmol Vis Sci. 2002 Mar;43(3):639-46. (PMID: 11867578)
Invest Ophthalmol Vis Sci. 2012 Aug 17;53(9):5632-40. (PMID: 22789921)
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4593-4600. (PMID: 28892827)
J Immunol. 2012 Jan 15;188(2):793-9. (PMID: 22156346)
J Proteome Res. 2012 Aug 3;11(8):4013-23. (PMID: 22663354)
Br J Exp Pathol. 1948 Feb;29(1):58-69. (PMID: 18865105)
Cornea. 2002 May;21(4):405-9. (PMID: 11973391)
Immunology. 2017 Apr;150(4):397-407. (PMID: 28108991)
J Immunol. 2006 Apr 1;176(7):3950-7. (PMID: 16547229)
Invest Ophthalmol Vis Sci. 2014 Aug 19;55(9):5871-7. (PMID: 25139737)
J Immunol. 2009 Mar 1;182(5):2753-65. (PMID: 19234170)
J Immunol. 2000 Apr 15;164(8):4307-12. (PMID: 10754330)
JAMA Ophthalmol. 2016 Feb;134(2):167-73. (PMID: 26633035)
Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3871-7. (PMID: 11053288)
J Control Release. 2017 Jul 28;258:208-217. (PMID: 28501670)
J Immunol. 2012 Jun 15;188(12):5962-9. (PMID: 22593618)
J Immunol. 1997 Dec 15;159(12):6283-90. (PMID: 9550433)
Prog Retin Eye Res. 2003 May;22(3):359-89. (PMID: 12852491)
J Immunol. 2017 Feb 15;198(4):1706-1717. (PMID: 28062697)
J Autoimmun. 2017 Feb;77:96-103. (PMID: 27899224)
Arch Ophthalmol. 1992 Oct;110(10):1392-403. (PMID: 1417537)
Nat Med. 2009 Sep;15(9):1023-30. (PMID: 19668192)
Exp Eye Res. 2007 May;84(5):939-50. (PMID: 17399701)
Pulm Pharmacol Ther. 2003;16(3):121-30. (PMID: 12749828)
Immunity. 2009 Sep 18;31(3):502-12. (PMID: 19733097)
J Immunol. 2011 Oct 1;187(7):3653-62. (PMID: 21880984)
Exp Eye Res. 2011 Mar;92(3):209-20. (PMID: 21195713)
J Leukoc Biol. 2012 Apr;91(4):621-7. (PMID: 22291211)
Amino Acids. 2013 Jul;45(1):41-53. (PMID: 22143431)
J Immunol. 2014 Nov 15;193(10):5264-72. (PMID: 25288568)
Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4293-301. (PMID: 15557435)
Invest Ophthalmol Vis Sci. 2013 Jan 28;54(1):813-20. (PMID: 23307967)
J Transplant. 2011;2011:246856. (PMID: 21941624)
J Neuroimmunol. 2013 Jul 15;260(1-2):9-16. (PMID: 23689030)
Front Immunol. 2013 Aug 07;4:232. (PMID: 23966994)
Int Rev Immunol. 2013 Feb;32(1):19-41. (PMID: 23360156)
J Allergy Clin Immunol. 2009 Dec;124(6):1333-42.e1. (PMID: 19748659)
Dev Ophthalmol. 2008;41:298-312. (PMID: 18453777)
Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2702-9. (PMID: 19151401)
PLoS One. 2013 May 14;8(5):e64193. (PMID: 23691170)
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11405-10. (PMID: 16849433)
mBio. 2015 Oct 27;6(6):e01426-15. (PMID: 26507231)
Mucosal Immunol. 2014 Mar;7(2):417-27. (PMID: 24022789)
J Immunol. 2011 Jun 15;186(12):6737-45. (PMID: 21551366)
J Leukoc Biol. 2011 Nov;90(5):883-95. (PMID: 21807741)
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2614-21. (PMID: 10509657)
Immunol Cell Biol. 2009 Feb;87(2):141-8. (PMID: 18936773)
Transplantation. 1997 May 27;63(10):1501-7. (PMID: 9175817)
Cornea. 2000 Sep;19(5):625-43. (PMID: 11009315)
J Immunol. 2016 May 15;196(10):3983-91. (PMID: 27183635)
J Immunol. 2007 Sep 15;179(6):3672-9. (PMID: 17785803)
Exp Eye Res. 2004 Mar;78(3):579-89. (PMID: 15106938)
Trends Immunol. 2002 Sep;23(9):445-9. (PMID: 12200066)
Ocul Surf. 2016 Jul;14(3):331-41. (PMID: 27154035)
Amino Acids. 2013 Jul;45(1):25-39. (PMID: 22139413)
Cornea. 2016 Nov;35 Suppl 1:S49-S54. (PMID: 27631349)
Eur J Immunol. 2005 Sep;35(9):2591-7. (PMID: 16114107)
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4459-67. (PMID: 17898266)
Am J Pathol. 2011 Apr;178(4):1922-9. (PMID: 21435468)
Invest Ophthalmol Vis Sci. 2013 Jun 12;54(6):4081-91. (PMID: 23702781)
Transplantation. 2016 Mar;100(3):525-32. (PMID: 26881788)
Regul Pept. 2000 Sep 25;93(1-3):53-64. (PMID: 11033053)
Exp Eye Res. 2013 Dec;117:53-61. (PMID: 23880529)
Exp Eye Res. 1995 Jun;60(6):659-65. (PMID: 7641848)
J Cell Physiol. 2004 Nov;201(2):167-80. (PMID: 15334652)
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4489-94. (PMID: 16303939)
Nat Med. 2014 Jan;20(1):62-8. (PMID: 24362934)
Immunity. 2009 Feb 20;30(2):277-88. (PMID: 19200757)
Am J Ophthalmol. 2006 Nov;142(5):736-44. (PMID: 17056357)
Am J Transplant. 2015 Jun;15(6):1490-501. (PMID: 25872977)
Immunity. 2013 Nov 14;39(5):949-62. (PMID: 24238343)
Cell Mol Life Sci. 2016 Nov;73(22):4249-4264. (PMID: 27314883)
Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4108-16. (PMID: 11095603)
Ocul Surf. 2017 Jan;15(1):2-14. (PMID: 27840126)
Sci Rep. 2016 Dec 23;6:39924. (PMID: 28008995)
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):581-9. (PMID: 12556386)
Sci Rep. 2017 Aug 29;7(1):9880. (PMID: 28852195)
J Immunol. 2004 Oct 1;173(7):4464-9. (PMID: 15383577)
Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3418-23. (PMID: 20019373)
Sci Rep. 2011;1:8. (PMID: 22355527)
Nature. 2006 Oct 26;443(7114):993-7. (PMID: 17051153)
Cornea. 2001 Jan;20(1):1-13. (PMID: 11188989)
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):1330-1336. (PMID: 28241321)
J Immunol. 2016 Nov 15;197(10):4021-4033. (PMID: 27798158)
PLoS One. 2015 Mar 20;10(3):e0120284. (PMID: 25793763)
J Immunol. 2009 Jan 1;182(1):148-53. (PMID: 19109145)
Immunol Rev. 2010 Mar;234(1):282-304. (PMID: 20193026)
Mucosal Immunol. 2010 Jan;3(1):17-28. (PMID: 19890268)
Autoimmun Rev. 2014 Jun;13(6):668-77. (PMID: 24418308)
Invest Ophthalmol Vis Sci. 1991 Jul;32(8):2201-11. (PMID: 2071334)
Ocul Surf. 2016 Jul;14(3):342-9. (PMID: 27189865)
J Leukoc Biol. 2013 Dec;94(6):1293-301. (PMID: 23983225)
Mucosal Immunol. 2017 May;10(3):743-756. (PMID: 27706128)
Ocul Surf. 2008 Jul;6(3):108-16. (PMID: 18781257)
J Immunol. 2009 Feb 1;182(3):1247-52. (PMID: 19155469)
Mucosal Immunol. 2014 Jan;7(1):38-45. (PMID: 23571503)
J Immunol. 2017 Aug 1;199(3):1163-1169. (PMID: 28637904)
Immunity. 2017 Apr 18;46(4):562-576. (PMID: 28423337)
Eur J Immunol. 2005 May;35(5):1567-75. (PMID: 15832292)
Mol Vis. 2010 Nov 20;16:2476-86. (PMID: 21139972)
Microbes Infect. 2005 Apr;7(4):799-810. (PMID: 15857807)
Exp Eye Res. 2010 Jun;90(6):655-63. (PMID: 20223235)
Immunity. 2017 Jul 18;47(1):6-8. (PMID: 28723553)
Invest Ophthalmol Vis Sci. 2000 Mar;41(3):805-10. (PMID: 10711697)
Nat Rev Mol Cell Biol. 2007 Jun;8(6):464-78. (PMID: 17522591)
J Immunol. 2009 Jan 1;182(1):623-35. (PMID: 19109196)
Expert Rev Clin Immunol. 2008 Jul;4(4):457-67. (PMID: 20477574)
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6556-65. (PMID: 20702832)
Immunity. 2017 Jul 18;47(1):148-158.e5. (PMID: 28709803)
Arch Ophthalmol. 1993 Jun;111(6):799-805. (PMID: 8512481)
Grant Information:: R01 EY012963 United States EY NEI NIH HHS; R01 EY020889 United States EY NEI NIH HHS; R01 EY024602 United States EY NEI NIH HHS
Entry Date(s):: Date Created: 20171218 Date Completed: 20181217 Latest Revision: 20231112
Update Code:: 20240104
PubMed Central ID:: PMC5880704
DOI:: 10.1016/j.it.2017.11.007
PMID:: 29248310
: Czasopismo naukowe

Full Text Finder

The ocular surface is a unique mucosal immune compartment in which anatomical, physiological, and immunological features act in concert to foster a particularly tolerant microenvironment. These mechanisms are vital to the functional competence of the eye, a fact underscored by the devastating toll of excessive inflammation at the cornea - blindness. Recent data have elucidated the contributions of specific anatomical components, immune cells, and soluble immunoregulatory factors in promoting homeostasis at the ocular surface. We highlight research trends at this distinctive mucosal barrier and identify crucial gaps in our current knowledge.
(Copyright © 2017 Elsevier Ltd. All rights reserved.)

Informacja